Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
Main Authors: | , , , , , , , |
---|---|
Format: | Conference item |
Published: |
2003
|
_version_ | 1826299014297944064 |
---|---|
author | Maini, R Taylor, P Pavelka, K Emery, P Szechinski, J Balint, G Broll, J Grp, C |
author_facet | Maini, R Taylor, P Pavelka, K Emery, P Szechinski, J Balint, G Broll, J Grp, C |
author_sort | Maini, R |
collection | OXFORD |
description | |
first_indexed | 2024-03-07T04:55:28Z |
format | Conference item |
id | oxford-uuid:d6750948-58a6-4ef3-abca-46f737d45318 |
institution | University of Oxford |
last_indexed | 2024-03-07T04:55:28Z |
publishDate | 2003 |
record_format | dspace |
spelling | oxford-uuid:d6750948-58a6-4ef3-abca-46f737d453182022-03-27T08:33:34ZEfficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:d6750948-58a6-4ef3-abca-46f737d45318Symplectic Elements at Oxford2003Maini, RTaylor, PPavelka, KEmery, PSzechinski, JBalint, GBroll, JGrp, C |
spellingShingle | Maini, R Taylor, P Pavelka, K Emery, P Szechinski, J Balint, G Broll, J Grp, C Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA). |
title | Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA). |
title_full | Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA). |
title_fullStr | Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA). |
title_full_unstemmed | Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA). |
title_short | Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA). |
title_sort | efficacy of il 6 receptor antagonist mra in rheumatoid arthritis patients with an incomplete response to methotrexate charisma |
work_keys_str_mv | AT mainir efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma AT taylorp efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma AT pavelkak efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma AT emeryp efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma AT szechinskij efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma AT balintg efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma AT brollj efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma AT grpc efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma |